[Dynamics of the soluble CD50-antigen level in patients with breast cancer in the course of combined therapy].
Immune enzyme assay with polyclonal and monoclonal antibodies was made use of to investigate the dynamic changes of soluble CD50-antigen in patients with breast cancer during chemotherapy and surgical treatment. A dependence of the content of the above antibody on a variety of parameters characterizing the tumor process and patients age was detected. The determination of a dynamic level of this protein provides for evaluating the efficiency of a treatment scheme.
Aliasova
A V
AV
Varshavskaia
L V
LV
Novikov
V V
VV
Baryshnikov
A Iu
AIu
D000328:Adult; D000367:Age Factors; D000368:Aged; D015703:Antigens, CD / Q000097:blood*; D014408:Biomarkers, Tumor / Q000097:blood; D001943:Breast Neoplasms / Q000097:blood / Q000276:immunology* / Q000473:pathology; D015815:Cell Adhesion Molecules; D005260:Female; D006801:Humans; D008875:Middle Aged; D009362:Neoplasm Metastasis; D012995:Solubility
D015703:Antigens, CD; D014408:Biomarkers, Tumor; D015815:Cell Adhesion Molecules; C483616:ICAM3 protein, human